The argument against the appropriateness of over-the-counter statins

被引：8

作者：

Barter, Philip J.

Rye, Kerry-Anne

机构：

[1] Univ Sydney, Heart Res Inst, Sydney, NSW 2006, Australia

[2] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia

[3] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

来源：

CIRCULATION | 2006年 / 114卷 / 12期

关键词：

D O I：

10.1161/CIRCULATIONAHA.105.604991

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1315 / 1320

页数：6

共 35 条

[1]

[Anonymous], 2002, JAMA

[2] High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].

Assmann, G ;

Schulte, H ;

vonEckardstein, A ;

Huang, YD .

ATHEROSCLEROSIS, 1996, 124 :S11-S20

[3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[4] Risk for myopathy with statin therapy in high-risk patients [J].

Ballantyne, CM ;

Corsini, A ;

Davidson, MH ;

Holdaas, H ;

Jacobson, TA ;

Leitersdorf, E ;

März, W ;

Reckless, JPD ;

Stein, EA .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :553-564

[5] Metabolic abnormalities: high-density lipoproteins [J].

Barter, P .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (02) :393-+

[6] Safety of statins - Focus on clinical pharmacokinetics and drug interactions [J].

Bellosta, S ;

Paoletti, R ;

Corsini, A .

CIRCULATION, 2004, 109 (23) :50-57

[7]

Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M

[8] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[9]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[10] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

← 1 2 3 4 →